Equities

Market movers

Constituents of the FTSE 350 with the highest percent gain over one day.
ListingLastChangeVolume
Keller Group PLCKLR:LSE2,205.00
GBX
+205.00
+10.25%
343.39k
Ithaca Energy PLCITH:LSE246.50
GBX
+12.50
+5.34%
4.94m
Smith & Nephew PLCSN.:LSE1,360.00
GBX
+47.00
+3.58%
3.68m
Bytes Technology Group PLCBYIT:LSE306.60
GBX
+8.00
+2.68%
507.88k
Plus500 LtdPLUS:LSE4,164.00
GBX
+104.00
+2.56%
508.47k
Greggs PLCGRG:LSE1,605.00
GBX
+34.00
+2.16%
1.10m
Energean PLCENOG:LSE919.50
GBX
+16.50
+1.83%
476.91k
Hays PLCHAS:LSE39.32
GBX
+0.600
+1.55%
6.05m
AJ Bell PLCAJB:LSE435.00
GBX
+5.00
+1.16%
894.15k
Harbour Energy PLCHBR:LSE274.60
GBX
+3.00
+1.10%
9.26m
Data delayed at least 15 minutes, as of Mar 03 2026 16:35 GMT.

Mergers and acquisitions

Mergers and acquisitions across all companies with an updated deal status over the last 90 days

CompaniesDeal statusDeal valueDate
Netflix Inc acquired Warner Bros Discovery IncDeal withdrawn71.51bn USD05 Dec 2025
Devon Energy Corp acquired Coterra Energy IncAnnounced21.60bn USD02 Feb 2026
Boston Scientific Corp acquired Penumbra IncAnnounced15.05bn USD15 Jan 2026
Danaher Corp acquired Masimo CorpAnnounced13.55bn USD17 Feb 2026
International Business Machines Corp acquired Confluent IncAnnounced12.44bn USD08 Dec 2025
71 total results

Institutional Ownership

Company% of available shares heldNet share increase since last reportedValue of change
PYC Therapeutics LtdPYC:ASX14.38%+55,273.57%123.82m AUD
Karyopharm Therapeutics IncKPTI:NSQ5.51%+1,119.74%6.57m USD
Ventyx Biosciences IncVTYX:NSQ6.20%+994.40%62.02m USD
RAPT Therapeutics IncRAPT:NMQ5.38%+407.48%85.72m USD
ContextLogic Holdings IncLOGC:QBB68.17%+356.03%143.78m USD
Amundi Index Solutions - Amundi MSCI Emerging Markets Swap UCITS ETF EUR AccAEEM:PAR:EUR0.00%-1.00%-95.48k EUR
ProShares UltraPro Dow30UDOW:PCQ:USD0.00%-1.00%-347.56k USD
Signing Day Sports IncSGN:ASQ0.00%-1.00%-217.21k USD
Clough Global Dividend and Income FundGLV:ASQ0.00%-1.00%-22.48k USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.